Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma-Reference-Cited by-同舟云学术

Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma

Published:2003-11 Issue:52 Volume:22 Page:8386-8393
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Hideshima Teru,Chauhan Dharminder,Hayashi Toshiaki,Akiyama Masaharu,Mitsiades Nicholas,Mitsiades Constantine,Podar Klaus,Munshi Nikhil C,Richardson Paul G,Anderson Kenneth C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1207170.pdf

Reference45 articles.

1. Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R . (1999). Immunity, 10, 105–115.

2. Chauhan D, Hideshima T, Pandey P, Treon S, Teoh G, Raje N, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S and Anderson KC . (1999). Oncogene, 18, 6733–6740.

3. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW and Anderson KC . (1997a). Blood, 89, 227–234.

4. Chauhan D, Kharbanda SM, Ogata A, Urashima M, Frank D, Malik N, Kufe DW and Anderson KC . (1995). J. Exp. Med., 182, 1801–1806.

5. Chauhan D, Pandey P, Hideshima T, Treon S, Raje N, Davies FE, Shima Y, Tai YT, Rosen S, Avraham S, Kharbanda S and Anderson KC . (2000). J. Biol. Chem., 275, 27845–27850.

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primed for Interactions: Investigating the Primed Substrate Channel of the Proteasome for Improved Molecular Engagement;Molecules;2024-07-17

2. Proteasome Inhibitors in Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

3. IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma?;Life;2023-11-20

4. Overcoming proteasome inhibitor resistance in the immunotherapy era;Trends in Pharmacological Sciences;2023-08

5. Steps towards a Multiple Myeloma Cure?;Journal of Personalized Medicine;2022-09-03